Alamar Biosciences, Inc. - 8-K Filing
Alamar Biosciences reports Q3 2026 revenue of $33.5 million and raises full-year guidance to $121M-$123M. (Items: 2.02 Results of Operations and Financial Condition, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $ALMR